NEUROCRINE BIOSCIENCES INC (NBIX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $36.77M2009: $3.95M2010: $19.34M2011: $60.08M2012: $154.37M2013: $120.41M2014: $208.70M2015: $424.45M2016: $314.88M2017: $372.20M2018: $480.80M2019: $636.90M2020: $1.13B2021: $1.37B2022: $1.71B2023: $2.23B2024: $2.59B2025: $3.25B$3.25B
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$3.25B+25.6%
2024$2.59B+16.0%
2023$2.23B+30.7%
2022$1.71B+24.3%
2021$1.37B+22.0%
2020$1.13B+76.8%
2019$636.90M+32.5%
2018$480.80M+29.2%
2017$372.20M+18.2%
2016$314.88M-25.8%
2015$424.45M+103.4%
2014$208.70M+73.3%
2013$120.41M-22.0%
2012$154.37M+156.9%
2011$60.08M+210.6%
2010$19.34M+389.3%
2009$3.95M-89.2%
2008$36.77M